Advertisement

Non-Malignant Lymphoproliferation

  • Irina Kondratenko
  • Olga Pashchenko
  • Andrey Bologov
Chapter

Abstract

Atypical manifestations of activated phosphoinositide 3-kinase δ syndrome type 2 (APDS2) can include warts, mild infections, and selective IgA deficiency

APDS2 must be differentiated from other primary immunodeficiency disroders with lymphoproliferation, infections and hypogammaglobulinemia.

Rapamycin is the most specific, pathology directed treatment for APDS type 2

Keywords

Rapamycin mTOR Activated PI3K-delta syndrome type 2 Lymphoproliferation 

References

  1. 1.
    Dufour C, Miano M, Fioredda F. Old and new faces of neutropenia in children. Haematologica. 2016;101(7):789–91.CrossRefGoogle Scholar
  2. 2.
    Yazdani R, Azizi G, Abolhassani H, Aghamohammadi A. Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management. Scand J Immunol. 2017;85(1):3–12.CrossRefGoogle Scholar
  3. 3.
    Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, Lucas CL, Matthews H, Deau MC, Sharapova S, Curtis J, Reichenbach J, Glastre C, Parry DA, Arumugakani G, McDermott E, Kilic SS, Yamashita M, Moshous D, Lamrini H, Otremba B, Gennery A, Coulter T, Quinti I, Stephan JL, Lougaris V, Brodszki N, Barlogis V, Asano T, Galicier L, Boutboul D, Nonoyama S, Cant A, Imai K, Picard C, Nejentsev S, Molina TJ, Lenardo M, Savic S, Cavazzana M, Fischer A, Durandy A, Kracker S. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study. J Allergy Clin Immunol. 2016;138(1):210–8.e9.CrossRefGoogle Scholar
  4. 4.
    Serwas NK, Cagdas D, Ban SA, Bienemann K, Salzer E, Tezcan I, Borkhardt A, Sanal O, Boztug K. Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia. Blood. 2014;124(4):655–7.CrossRefGoogle Scholar
  5. 5.
    Gulino AV. WHIM syndrome: a genetic disorder of leukocyte trafficking. Curr Opin Allergy Clin Immunol. 2003;3(6):443–50.CrossRefGoogle Scholar
  6. 6.
    Gilmour KC, Gaspar HB. Pathogenesis and diagnosis of X-linked lymphoproliferative disease. Expert Rev Mol Diagn. 2003;3(5):549–61.CrossRefGoogle Scholar
  7. 7.
    Punwani D, Pelz B, Yu J, Arva NC, Schafernak K, Kondratowicz K, Makhija M, Puck JM. Coronin-1A: immune deficiency in humans and mice. J Clin Immunol. 2015;35(2):100–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Irina Kondratenko
    • 1
    • 2
  • Olga Pashchenko
    • 2
  • Andrey Bologov
    • 2
  1. 1.Department of Clinical Immunology and RheumatologyRussian Children’s Clinical Hospital of Pirogov Russian National Research Medical UniversityMoscowRussia
  2. 2.Department of ImmunologyPirogov Russian National Research Medical UniversityMoscowRussia

Personalised recommendations